News

Track Our News on

2025-06-19

MindRank Announces Positive Phase 2b Results for AI-Designed Oral GLP-1 Receptor Agonist MDR-001 in Adults with Obesity or Overweight

2025-04-18

Inform. Fusion | Adaptive symmetry-based adversarial perturbation augmentation for molecular graph representations with dual-fusion attention information

2025-03-07

Dual WEE1/YES1 Kinase Inhibitor MRANK-106 Secures FDA IND Clearance, Positioning MindRank in First-in-Class Oncology Pipeline

2024-09-14

Scientific Data | PharmaBench: Enhancing ADMET benchmarks with large language models

2024-07-29

MindRank Begins IND-Enabling Studies of its AI-Designed Molecular Glue Drug Pipeline MRANK-103

2024-06-11

MindRank Recognized in 2024 WAIC SAIL Award TOP30 List

2024-05-22

MindRank and HISUN (600267.SH) Forge Strategic Partnership to Advance AI-Empowered Innovative Drug Discovery

2024-04-29

MindRank Named as One of the Top 10 Emerging AI Tech Companies by Forbes China

2024-04-15

MindRank Honored in Global Health & Pharma Magazine's 2024 Biotechnology Awards Winners

2024-04-02

MindRank and BioMetas Announce Strategic Partnership to Establish One-Stop Service Platform for AI+ Drug Research and Development

2024-03-20

J. Cheminform. | Automated molecular structure segmentation from documents using ChemSAM

2024-03-12

ChemRxiv | A Smart Strategy for Photoresponsive Molecules: Utilizing Generative Pre-trained Transformer and TDDFT Calculations in Drug Delivery

1 / 5